118071-31-1 ((H-Ser-Gln-Asn-Tyr-Pro-Ile-Val-OH)

ser-gln-asn-tyr-pro-ile-val;2-[[2-[[1-[2-[[4-amino-2-[[5-amino-2-[(2-amino-3-hydroxypropanoyl)amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-;H-SER-GLN-ASN-TYR-PRO-ILE-VAL-OH;SER-GLU-ASN-TYR-PRO-ILE-VAL;SQNYPIV;HIV GAG (129-135);HIV gag fragment 129-135;HIV-1 GAG (AA 77-436) STRAIN IIIB;DTXSID90595930;2-[[2-[[1-[2-[[4-amino-2-[[5-amino-2-[(2-amino-3-hydroxypropanoyl)amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoic acid;118071-31-1;SCHEMBL7279684;Serylglutaminylasparaginyltyrosylprolylisoleucylvaline;

XMQYBJNICRKTBW-UHFFFAOYSA-N

1S/C37H57N9O12/c1-5-19(4)30(35(55)44-29(18(2)3)37(57)58)45-34(54)26-7-6-14-46(26)36(56)25(15-20-8-10-21(48)11-9-20)43-33(53)24(16-28(40)50)42-32(52)23(12-13-27(39)49)41-31(51)22(38)17-47/h8-11,18-19,22-26,29-30,47-48H,5-7,12-17,38H2,1-4H3,(H2,39,49)(H2,40,50)(H,41,51)(H,42,52)(H,43,53)(H,44,55)(H,45,54)(H,57,58)

O=C(C1CCCN1C(C(CC1C=CC(=CC=1)O)NC(C(CC(N)=O)NC(C(CCC(N)=O)NC(C(CO)N)=O)=O)=O)=O)NC(C(NC(C(=O)O)C(C)C)=O)C(C)CC